Outline
- PBPK model description
- Exploring mechanisms affecting in vivo dissolution of low-solubility compound crystalline suspensions
- Effect of inflammation
- Example Paliperidone Palmitat
- Effect of dissolution rate –Example Cabotegravir
- Putting it all together
By Viera Lukacova
Presented at AAPS “Patient-Centric Design of Long-Acting Injectable Drug Products” Workshop Virtual Event March 9-10, 2022